Creative Diagnostics Announces Comprehensive Vaccine Development CRO Services
Creative Diagnostics introduces comprehensive Vaccine Development CRO Services. NEW YORK, NY, UNITED STATES, February 22, 2025 /EINPresswir ...
Creative Diagnostics Launches Innovative Norovirus VP1 VLP Panel For Research Use
Creative Diagnostics announces the launch of its new Norovirus VP1 VLP Panel to support NoV research. NEW YORK, NY, UNITED STATES, February ...
Genocea Biosciences (NASDAQ:GNCA) Coverage Initiated by Analysts at StockNews.com
Equities research analysts at StockNews.com assumed coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Get Free Report) in a research report issued to clients and investors on Saturday. The ...
Le Lézard21h
TROP2 Antibody Market Report: Clinical Trials Pave the Way, Revolutionizing Cancer Treatment - ResearchAndMarkets.com
The "Global TROP2 Antibody Market & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering. In what marks a significant leap forward in precision oncology, the TROP2 ...
Targeted Oncology4h
Gasparetto Explains Rationale for Quadruplet Front Line in Transplant-Ineligible Myeloma
In a Community Case Forum in partnership with the North Carolina Oncology Association, Cristina Gasparetto, MD, discussed the ...
Irish Examiner on MSN15h
Prostate cancer screening pilot scheme in Waterford and Dublin
Trial scheme involving self testing at home followed by MRI scans promises faster access to prostate cancer treatment in ...
Targeted Oncology23h
FDA Grants Fast Track Designation to 67Cu-SAR-bisPSMA in mCRPC
The FDA has granted fast track status to 67Cu-SAR-bisPSMA for metastatic prostate cancer that is resistant to hormone therapy ...